 VALENCIA, Calif., Oct. 29, 2020 GLOBE NEWSWIRE -- AVITA Therapeutics, Inc. NASDAQ: RCEL, ASX:AVH, a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, wishes to advise that its 2020 Annual Stockholder Meeting the Annual Meeting, which was scheduled to be held today, October 29, 2020 at 1.00 p.m. Pacific Time being Friday, October 30, 2020 at 7.00 a.m. Australian Eastern Daylight Time AEDT, was convened and adjourned, without any business being conducted, due to the lack of the required quorum. 